BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31933068)

  • 1. The diagnostic value of serum DSA-TRF in hepatocellular carcinoma.
    Guan W; Gao Z; Huang C; Fang M; Feng H; Chen S; Wang M; Zhou J; Hong S; Gao C
    Glycoconj J; 2020 Apr; 37(2):231-240. PubMed ID: 31933068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
    Mao L; Wang Y; Wang D; Han G; Fu S; Wang J
    PLoS One; 2017; 12(9):e0183880. PubMed ID: 28902891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimisation of quantitative miRNA panels to consolidate the diagnostic surveillance of HBV-related hepatocellular carcinoma.
    Tat Trung N; Duong DC; Tong HV; Hien TTT; Hoan PQ; Bang MH; Binh MT; Ky TD; Tung NL; Thinh NT; Sang VV; Thao LTP; Bock CT; Velavan TP; Meyer CG; Song LH; Toan NL
    PLoS One; 2018; 13(4):e0196081. PubMed ID: 29672637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. sFRP-4, a potential novel serum marker for chronic hepatitis B-related hepatocellular carcinoma.
    Xu C; Zeng XH; Wang L; Tao SQ; Wu QX; Zhu P; Deng GH; Wang YM
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):164-70. PubMed ID: 25865689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum miR-224 as a biomarker for detection of hepatocellular carcinoma at early stage.
    Lin L; Lu B; Yu J; Liu W; Zhou A
    Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):397-404. PubMed ID: 26724963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
    Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
    Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Large-Scale Multicenter Study Validates Aldo-Keto Reductase Family 1 Member B10 as a Prevalent Serum Marker for Detection of Hepatocellular Carcinoma.
    Ye X; Li C; Zu X; Lin M; Liu Q; Liu J; Xu G; Chen Z; Xu Y; Liu L; Luo D; Cao Z; Shi G; Feng Z; Deng H; Liao Q; Cai C; Liao DF; Wang J; Jin J; Cao D
    Hepatology; 2019 Jun; 69(6):2489-2501. PubMed ID: 30672601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent transforming growth factor-beta binding protein-1 in circulating plasma as a novel biomarker for early detection of hepatocellular carcinoma.
    Cao B; Yang L; Rong W; Feng L; Han N; Zhang K; Cheng S; Wu J; Xiao T; Gao Y
    Int J Clin Exp Pathol; 2015; 8(12):16046-54. PubMed ID: 26884881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A preliminary study of serum marker alpha-enolase in the diagnosis of hepatocellular carcinoma].
    Luo X; Wei YQ; Hai L; Hu YC; Zhao ZJ; Ma WL; Ma LN; Liu XY; Ding XC
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):505-510. PubMed ID: 31357775
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum N-glycan profiling as a diagnostic biomarker for the identification of hepatitis B virus-associated hepatocellular carcinoma.
    Guo L; Wan L; Hu Y; Huang H; He B; Wen Z
    J Gastrointest Oncol; 2022 Feb; 13(1):344-354. PubMed ID: 35284106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Zonulin in HBV-Associated Chronic Hepatitis, Liver Cirrhosis, and Hepatocellular Carcinoma.
    Wang X; Li MM; Niu Y; Zhang X; Yin JB; Zhao CJ; Wang RT
    Dis Markers; 2019; 2019():5945721. PubMed ID: 31485278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma.
    Sun Y; Zhu S; Wu Z; Huang Y; Liu C; Tang S; Wei L
    Oncotarget; 2017 Apr; 8(14):23427-23435. PubMed ID: 28178643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
    Comunale MA; Wang M; Rodemich-Betesh L; Hafner J; Lamontagne A; Klein A; Marrero J; Di Bisceglie AM; Gish R; Block T; Mehta A
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1222-9. PubMed ID: 21467232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Evaluation of Des-Gamma-Carboxy Prothrombin versus α-Fetoprotein for Hepatitis B Virus-Related Hepatocellular Carcinoma in China: A Large-Scale, Multicentre Study.
    Ji J; Wang H; Li Y; Zheng L; Yin Y; Zou Z; Zhou F; Zhou W; Shen F; Gao C
    PLoS One; 2016; 11(4):e0153227. PubMed ID: 27070780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 4210 Da and 1866 Da polypeptides as potential biomarkers of liver disease progression in hepatitis B virus patients.
    Ren Y; Yang L; Li M; Wang J; Yan H; Ma N; Liu W; Wang L; Gao X; Gao P; Li T; Liu D
    Sci Rep; 2021 Aug; 11(1):16982. PubMed ID: 34417517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma.
    Wang WW; Ang SF; Kumar R; Heah C; Utama A; Tania NP; Li H; Tan SH; Poo D; Choo SP; Chow WC; Tan CK; Toh HC
    PLoS One; 2013; 8(7):e68904. PubMed ID: 23874805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver Cancer-Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma.
    Lu F; Shah PA; Rao A; Gifford-Hollingsworth C; Chen A; Trey G; Soryal M; Talat A; Aslam A; Nasir B; Choudhry S; Ishtiaq R; Sanoff H; Conteh LF; Noonan A; Hu KQ; Schmidt C; Fu M; Civan J; Xiao G; Lau DT; Lu X
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00271. PubMed ID: 33512798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum talin-1 is a potential novel biomarker for diagnosis of hepatocellular carcinoma in Egyptian patients.
    Youns MM; Abdel Wahab AH; Hassan ZA; Attia MS
    Asian Pac J Cancer Prev; 2013; 14(6):3819-23. PubMed ID: 23886189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
    Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
    Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of plasma osteopontin in diagnosis of hepatitis C virus-related hepatocellular carcinoma.
    Nabih MI; Aref WM; Fathy MM
    Arab J Gastroenterol; 2014; 15(3-4):103-7. PubMed ID: 25249230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.